CHANGING THE PARADIGM FROM TREATMENT TO PREVENTION: A DIABETES CASE MODEL CONTEXT by Marsha Gold, Sc.D. Senior Fellow Presentation at the AcademyHealth National Health Policy Conference February 4, 2008 Context for This Session 1 Diabetes is a serious and costly illness both in human and economic terms. The burden is expected to grow even more substantial in the future. The prevalence of diabetes and extent of complications are to some extent preventable. What are we learning about ways to shift the paradigm? What stands in the way of greater progress? Illustrating the Challenges from the 60,000 Foot Level: Federal Programs, Policy and Spending Relevant to Diabetes 2 The logic model Federal department roles and responsibilities relevant to diabetes Federal spending on treatment and disability payments for those with diabetes (compared to those without) Other relevant spending: prevention, research and regulation, food assistance Acknowledgements and Caveats 3 Work funded with support of Novo Nordisk’s National Changing Diabetes Program Large team of staff from MPR To “think big” we had to make simplifying assumptions Results likely to be “roughly right” in overview but details may lack precision and comprehensiveness. Diabetes Contributes Substantially to Federal Costs 4 $79.7 billion in extra federal medical spending and $2.5 billion I SSDI/SSI disability payments We estimated the extra medical spending is 12 percent of all federal health spending in FY 2005 (one in eight dollars) Diabetes Treatment Related Costs by Agency Additional Federal Spending on Medical Care for Those With Diabetes vs. Without, FY 2005 DOD 4% VA 7% Other <1% FEHB 3% Medicaid (fed share) 6% Medicare 79% Total federal program spending = $77.2 billion Source: MPR analysis using cost of illness approach. Note: 5 Excludes any spending on prevention and screening that is the same for those with and without diabetes. The Federal Case for a Reframed Paradigm 6 Because of the epidemiology of diabetes, federal programs (especially covering aged and disabled) bear a disproportionate share of fiscal burden of diabetes. The federal government has many ways in which programs can influence the development and progression of diabetes. However many activities go under-recognized and uncoordinated. (e.g., CDC’s budget is only 11 percent of total relevant prevention funds.) Logic Model 7 Primary focus is on people and the progression of diabetes Progression influenced by (1) individual characteristics, (2) the broader social system in which they reside (family, community, broader environment), and (3) by health care system characteristics Prevention: central role of nutrition, physical activity, and obesity for general and high risk groups Screening to detect and treat diabetes early to manage care and avoid complications Logic Model - II 8 Ongoing treatment of diabetes and support for people who have impaired functioning due to diabetes Individual, health system, and social/environmental system variables influence success and ability to avoid disability and other adverse outcomes (including disability and death) Programs that account for different subgroups of the population at special risk Context: overall policy and social environment, level of knowledge (research/surveillance) Federal Activity Relevant to Diabetes - I 9 Prevention, Education and Assistance Programs: Diabetes focused work concentrated in CDC, NIH, and the Indian Health Service. Broader efforts at disease prevention and health promotion are more widely distributed (HHS, USDA, DOT, HUD, DOI, etc.) and not specific to diabetes. Medical Treatment and Disability Compensation: Medicare, Medicaid/SCHIP, Veterans Health Administration, DoD’s TRICARE, FEHBP, Indian Health Service, Social Security Administration and others. Federal Activity Relevant to Diabetes - II Policy and Regulatory Authority: Dietary guidelines (USDA/HHS); ERISA, Family and Medical Leave Act and disability policy (DOL); health claims and advertising (FTC); food and drugs (FDA); personal and business income tax policy (IRS). Research and Monitoring: NIH (various Institutes); other HHS agencies, USDA, VA, and DoD; national data systems (NCHS, AHRQ, Census Bureau, Labor and others); and FDA and other regulatory efforts. 10 Distribution of Prevention Spending Diabetes Specific 6% USDA 23% Other 19% a CDC 11% Other HHS 41% Total = $3.9 billion, including $3.7 billion in other programs related to physical activity, diet, and obesity. a Source: MPR analysis of federal spending, FY 2005. aIn addition, a portion of NIH’s $1.1 billion spending in diabetes research goes to support diabetes education and prevention. These funds are included in other parts of the estimates. 11 $3.1 Billion in Federal Funds Supports Research, Monitoring, and Regulation Relevant to Diabetes RESEARCH AND MONITORING (in billions) $3.053 Research $2.604 NIH diabetes related researcha $1.055 NIH research on related risk factors for diabetes $0.814 Other relevant research in HHS (AHRQ, CMS, CDC) $0.076 Other relevant research outside HHS (USDA, Other) $0.659 Statistical Systems to Support Monitoring $0.159 Related regulation (e.g., FDA, FTC, Commerce) $0.290 Source: MPR analysis of federal spending, FY 2005. aIncludes 12 NIH spending for diabetes education and prevention. Federal Spending on Food Assistance Programs 13 About $48.9 billion is spent, mainly by USDA, on food programs (in addition to nutrition guidance). $16.5 billion is directly for food and $32.4 billion is spent on food stamps. Key programs include Food Stamps, WIC, Child Nutrition Programs (e.g., School Meals), HHS’ Nutrition Services for Older Persons, and others. Opportunities at Multiple Points Integrate prevention and effective care into treatment programs to reduce complications. Leverage families, communities, schools, and the workplace to encourage prevention, detection, and early treatment of diabetes. Use existing federal funds in housing, transportation, and other programs to build environments that encourage physical activity. Draw upon the large amount spent on food assistance programs to promote healthy eating and physical activity. 14 Areas for Future Consideration 1. The federal government should take steps to get the most out of current spending in medical and treatment programs. 2. The federal government should lead by example and effectively promote the health of its workforce. 3. The federal government should enhance interdepartmental coordination and more effectively apply its resources to reduce the risk factors for and complications of diabetes within the U.S. population. 15 Logic Model for Diabetes Presentation Characteristics Health Care System Insurance Coverage Access to Healthcare Provider Supply and Mix Primary Care Provider Knowledge Policies regarding Reimbursements/ Incentives Federal and State Policies, Regulations, Surveillance, and Other Activities (e.g., agriculture, transportation, etc.) People Age Race/Ethnic Group Immigration Status SES/Insurance Coverage Family History Obesity Status Pregnancy Status Nutrition Physical Activity Family/Community/ Built Environment Community Wealth Availabiilty of Healthy, Culturally Appropriate Food Neighborhood Walkability/Safety Nutrition/Physical Activity in Schools Family Policy/ Support Socialization of New Immigrants Transportation Diabetes Prevention Physician Incentives Benefits for Preventative Care Reimbursement for Obesity Counseling/ Treatment Provider Education Diabetes Prevention Programs Nutrition Programs Physical Activity Programs Obesity Prevention Programs Screening/Counseling Programs Advertising/Health Promotion School Nutrition Policies Physical Activity Programs in Schools Nutrition Education/ Healthy Food in Food Assistance Programs Workplace Physical Activity Promotion Diabetes Detection Diabetes Treatment Physician Incentives Reimbursement for Screening Provider Education Clinical Guidelines Screening and Detection Programs Community Health Fairs Workplace Screening Programs Provider Education Payment Policy Subsidized Services Chronic Care Management Clinical Guidelines Differences in Treatment by Provider Type Medication Compliance Self Monitoring Physician Monitoring Co-morbidities Campaigns to Reduce Stigma Patient and Family Empowerment Policies Workplace Accomodations Assistance from Charitable Organizations Research on Effective Interventions within Settings and Populations Source: Mathematica Policy Research, Inc. 16 Management of Diabetes with Complications Adverse Events Disability Death Income and Disability Policy Where to get information: http://www.mathematica-mpr.com/health/diabetes.asp Reports “Study of Federal Spending on Diabetes: An Opportunity for Change” (June 2007) “Study of Federal Spending on Diabetes: An Opportunity for Change—Executive Summary” (June 2007) “Study of Federal Spending on Diabetes: An Opportunity for Change” (PowerPoint presentation, June 2007) Study of Federal Spending on Diabetes: Summaries of Federal Government Agencies and Their Relevant Activities. Working Papers” (January 2007) White Paper 17 “Federal Medical and Disability Program Costs Associated with Diabetes, 2005” (September 2007): Provides a focused looked at the construction of the $79 billion estimates of medical and disability costs that were included in the main study.